In this study, we directly investigated the impact of up‐regulation of p16 in human‐induced pluripotent stem cells (iPSCs) and iPSC‐derived cortical neurons on senescence and the development of AD pathologies. This evidence concerns the gene CDKN2A and Alzheimer disease.